Monthly information on share capital and company voting rights

Q: What is the current number of shares outstanding for Cellectis (CLLS) as of June 2025?

As of June 30, 2025, Cellectis has 100,325,229 total shares outstanding in its capital structure.

Q: How many voting rights does Cellectis (CLLS) have as of June 2025?

Cellectis reported 89,428,630 total voting rights as of June 30, 2025.

Q: Where is Cellectis (CLLS) stock listed?

Cellectis is listed on Euronext Growth with the ISIN code FR0010425595.

Q: Who should investors contact for Cellectis (CLLS) investor relations?

Investors can contact Arthur Stril, Chief Financial Officer & Chief Business Officer, at investors@cellectis.com.

Cellectis (NASDAQ:CLLS) has released its monthly share capital and voting rights report as of June 30, 2025.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Cellectis (NASDAQ:CLLS) has released its monthly share capital and voting rights report as of June 30, 2025. The company reported a total of 100,325,229 shares in its capital structure and 89,428,630 voting rights.

This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, as the company is listed on Euronext Growth.